Goldman Sachs Lifts Estimates and Price Target On Allergan (AGN) After Botox for Migraines
Tweet Send to a Friend
Goldman Sachs raised estimates and their price target on ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE